New drugs for bad bugs: dual-functional therapies to treat resistant bacteria

This project is developing new drugs for bacteria resistant to antimicrobials. By augmenting the host’s immune response and removing bacterial evasion mechanisms, it is hoped to overcome bacterial infections.

Lead organisation(s):

Monash University

Project type:
In progress

Simultaneous ‘drug-immune’ therapies will provide highly synergistic bacterial killing utilising existing antibiotic therapeutics, thus underlining the feasibility of future clinical application of such approaches.

For more information on this research or activity:

Edits to this research are currently being reviewed. If you want to update or request removal please email

Last updated:

Help us improve our website

If you would like a response please use the Feedback form instead.